Profund Advisors’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$745K Sell
11,044
-1,158
-9% -$70.2K 0.02% 420
2026
Q1
$677K Sell
12,202
-886
-7% -$47.7K 0.02% 457
2025
Q4
$635K Buy
13,088
+6,525
+99% +$254K 0.02% 478
2025
Q3
$201K Buy
+6,563
New +$151K 0.01% 987
2025
Q1
Sell
-13,496
Closed -$179K 996
2024
Q4
$179K Buy
13,496
+5,768
+75% +$140K 0.01% 1026
2024
Q3
$259K Sell
7,728
-1,482
-16% -$50.6K 0.01% 888
2024
Q2
$231K Sell
9,210
-4,936
-35% -$115K 0.01% 900
2024
Q1
$319K Buy
+14,146
New +$335K 0.01% 819
2023
Q4
Sell
-10,632
Closed -$191K 1132
2023
Q3
$191K Sell
10,632
-6,211
-37% -$119K 0.01% 899
2023
Q2
$343K Buy
16,843
+2,380
+16% +$48.3K 0.02% 651
2023
Q1
$315K Buy
+14,463
New +$351K 0.02% 692

Other funds holding ANAB

Profund Advisors's ANAB Position: Q2 2026 in Review

Profund Advisors reduced its AnaptysBio (ANAB) stake by 9.5% in Q2 2026, selling an estimated $70.2K and leaving 11,044 shares worth $745K. The position accounts for 0.02% of the portfolio, ranked #420.

Profund Advisors first reported a position in ANAB in Q1 2023 and has held it in 11 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Profund Advisors held 11,044 shares of AnaptysBio worth $745K as of Q2 2026.
  • Profund Advisors sold 1,158 AnaptysBio shares in Q2 2026, an estimated $70.2K.
  • AnaptysBio made up 0.02% of Profund Advisors's portfolio in Q2 2026, its #420 holding.
  • Profund Advisors first reported a position in AnaptysBio in Q1 2023 and has held it in 11 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.